Lei Fang

Corporate Officer/Principal at LEPU BIOPHARMA CO., LTD.

41 year

Health Technology

Consumer Services

Profile

Lei Fang is currently the Vice President at Lepu Biopharma Co., Ltd.
and also holds a current position at CtM Bio Co., Ltd.
Dr. Fang was previously the Director of Research & Development at I-MAB Biopharma Co., Ltd.
from 2016 to 2020.
Additionally, Dr. Fang was a Director at Third Venture Biopharma (Nanjing) Co., Ltd.
Dr. Fang received a doctorate degree from the Chinese Academy of Sciences and an undergraduate degree from Hebei University in 2004.

Lei Fang active positions

Companies	Position	Start
LEPU BIOPHARMA CO., LTD.	Corporate Officer/Principal	09/12/2020
CtM Bio Co., Ltd.	Chief Executive Officer	-

All active positions of Lei Fang

Former positions of Lei Fang

Companies	Position	End
I-MAB Biopharma Co., Ltd. I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China.	Chief Tech/Sci/R&D Officer	31/03/2020
Third Venture Biopharma (Nanjing) Co., Ltd.	Director/Board Member	-

See the detail of Lei Fang's experience

Training of Lei Fang

Hebei University	Undergraduate Degree
Chinese Academy of Sciences	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Lei Fang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
LEPU BIOPHARMA CO., LTD.	Health Technology

Private companies	3
I-MAB Biopharma Co., Ltd. I-MAB Biopharma Co., Ltd. BiotechnologyHealth Technology I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China.	Health Technology
CtM Bio Co., Ltd.
Third Venture Biopharma (Nanjing) Co., Ltd.

See company connections